Saleh, R., Chi, K. N., Jiang, D. M., Castonguay, V., Abbaspour, F., Metser, U., Wilson, D., Ma, J., Cioci, R., Nacerddine, K., Beauregard, J. (2025). ACCEL: [Ac-225]-PSMA-62 phase Ia/Ib/II clinical trial to characterize efficacy, safety, tolerability, and dosimetry in oligometastatic hormone-sensitive and metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps282